Publications by authors named "Maya Hellmich"

Claim this Profile
E
Elevated Bone Hardness Under Denosumab Treatment, With Persisting Lower Osteocyte Viability During Discontinuation.
Katharina Jähn-Rickert, Eva M Wölfel, Björn Jobke, Christoph Riedel, Maya Hellmich

Front Endocrinol (Lausanne)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis